Coronavirus News and Research

RSS

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

A partnership among Altimetrik, a Southfield-based fast-growing global business transformation company, the 501(c)(3) Vattikutti Foundation, Henry Ford Health System and the City of Detroit has provided more than 20,000 onsite COVID-19 tests to residents in 163 of Detroit's senior and congregate living facilities, as well as the city's first responders and essential workers.

23 Jul 2020

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Scrape your knee, and you'll see some red puffiness appear around the injury. This is inflammation, and it is driven by the immune system.

23 Jul 2020

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 -- the virus that causes the disease -- drop sharply over the first three months after infection, decreasing by roughly half every 73 days.

23 Jul 2020

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

For-profit status is associated with the extent of an outbreak of coronavirus disease 2019 (COVID-19) in long-term care (LTC) homes and the number of resident deaths from COVID-19, but not the likelihood of an outbreak, which was related to the infection rate in the surrounding local public health unit and the total number of beds in the home, found new research published in CMAJ (Canadian Medical Association Journal).

23 Jul 2020

Findings could help design vaccines against coronavirus

Scientists investigating the evolution of the virus that causes Covid19 say that its mutation seems to be directed by human proteins that degrade it, but natural selection of the virus enables it to bounce back. The findings could help in the design of vaccines against the virus.

23 Jul 2020

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Report highlights the need to improve quality of care for high-risk veterans

Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report.

22 Jul 2020

Georgia State researchers receive NSF grant to develop coronavirus test tools

Georgia State University researchers have received a one-year, $200,000 rapid response grant from the National Science Foundation to develop a tool to detect the presence of SARS-CoV-2, the virus causing the COVID-19 pandemic.

22 Jul 2020

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Researchers win grant to study why COVID-19 patients lose their sense of smell

Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.

22 Jul 2020

Scientists want to know more about using UV light to fight COVID-19 spread

High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.

22 Jul 2020

Essential and in danger: Coronavirus sickens, even kills public health workers

As a veteran public health worker, Chantee Mack knew the coronavirus could kill. She already faced health challenges and didn't want to take any chances during the pandemic. So she asked — twice — for permission to work from home.

22 Jul 2020

Study shows chloroquine does not prevent SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Sartorius raises 2020 sales and earnings forecast based on dynamic performance in the first half

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, raised its growth and earnings guidance for the current year based on its very dynamic business performance in the first six months of 2020, as well as on high demand expected to continue for the rest of the current fiscal year.

From Sartorius 22 Jul 2020

NHS Digital publishes new data on healthcare activity and outcomes for shielded patients

A new aggregate data set that provides information on healthcare activity and outcomes of shielded patients has been published by NHS Digital today.

22 Jul 2020

Study captures unexpected features of SARS-Cov-2 spike protein

The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic.

22 Jul 2020

Self-imposed prevention strategies can help mitigate COVID-19 epidemic

Both self-imposed prevention measures such as hand-washing, mask-wearing and social distancing, as well as government-imposed social distancing can help mitigate and delay a COVID-19 epidemic, according to a new study published this week in PLOS Medicine by Alexandra Teslya of University Medical Center Utrecht, Utrecht, The Netherlands and colleagues.

22 Jul 2020

Racially motivated hate crimes increase in the U.S.

Under the Hate Crime Statistic Act, hate crimes are defined as "crimes that manifest evidence of prejudice based on race, gender and gender identity, religion, disability, sexual orientation, or ethnicity."

22 Jul 2020

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that a Fortune 100 global consumer packaged goods company has deployed the LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.

From LabVantage Solutions 22 Jul 2020

Cancer diagnostic capacity should be ramped up to avoid unnecessary deaths, say researchers

Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand additional deaths in England, a new study reports.

22 Jul 2020

Coronavirus News and Research

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

Findings could help design vaccines against coronavirus

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Report highlights the need to improve quality of care for high-risk veterans

Georgia State researchers receive NSF grant to develop coronavirus test tools

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Researchers win grant to study why COVID-19 patients lose their sense of smell

Scientists want to know more about using UV light to fight COVID-19 spread

Essential and in danger: Coronavirus sickens, even kills public health workers

Study shows chloroquine does not prevent SARS-CoV-2

Sartorius raises 2020 sales and earnings forecast based on dynamic performance in the first half

NHS Digital publishes new data on healthcare activity and outcomes for shielded patients

Study captures unexpected features of SARS-Cov-2 spike protein

Self-imposed prevention strategies can help mitigate COVID-19 epidemic

Racially motivated hate crimes increase in the U.S.

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

Cancer diagnostic capacity should be ramped up to avoid unnecessary deaths, say researchers

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News